- Home
- LSAK vs PROC Comparison
LSAK vs PROC Comparison
Compare LSAK & PROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSAK
- PROC
- Stock Information
- Founded
- LSAK 1997
- PROC 1976
- Country
- LSAK South Africa
- PROC Luxembourg
- Employees
- LSAK N/A
- PROC N/A
- Industry
- LSAK Investment Bankers/Brokers/Service
- PROC Biotechnology: Pharmaceutical Preparations
- Sector
- LSAK Finance
- PROC Health Care
- Exchange
- LSAK Nasdaq
- PROC Nasdaq
- Market Cap
- LSAK N/A
- PROC 203.1M
- IPO Year
- LSAK N/A
- PROC N/A
- Fundamental
- Price
- LSAK $5.10
- PROC $1.90
- Analyst Decision
- LSAK
- PROC
- Analyst Count
- LSAK 0
- PROC 0
- Target Price
- LSAK N/A
- PROC N/A
- AVG Volume (30 Days)
- LSAK 18.4K
- PROC 9.8K
- Earning Date
- LSAK 11-06-2024
- PROC 11-12-2024
- Dividend Yield
- LSAK N/A
- PROC N/A
- EPS Growth
- LSAK N/A
- PROC N/A
- EPS
- LSAK N/A
- PROC 0.52
- Revenue
- LSAK $564,222,000.00
- PROC $414,096,000.00
- Revenue This Year
- LSAK $6.62
- PROC $5.54
- Revenue Next Year
- LSAK $7.87
- PROC $8.54
- P/E Ratio
- LSAK N/A
- PROC $3.68
- Revenue Growth
- LSAK 6.87
- PROC N/A
- 52 Week Low
- LSAK $3.00
- PROC $1.68
- 52 Week High
- LSAK $5.33
- PROC $4.95
- Technical
- Relative Strength Index (RSI)
- LSAK 58.96
- PROC 43.98
- Support Level
- LSAK $4.99
- PROC $1.77
- Resistance Level
- LSAK $5.08
- PROC $2.06
- Average True Range (ATR)
- LSAK 0.11
- PROC 0.11
- MACD
- LSAK 0.01
- PROC -0.02
- Stochastic Oscillator
- LSAK 100.00
- PROC 25.86
About PROC Procaps Group S.A.
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.